Literature DB >> 27253220

Development of Sulfonamide Photoaffinity Inhibitors for Probing Cellular γ-Secretase.

Christina J Crump1, Heather E Murrey2, T Eric Ballard3, Christopher W Am Ende3, Xianzhong Wu1, Natalya Gertsik1, Douglas S Johnson2, Yue-Ming Li1.   

Abstract

γ-Secretase is a multiprotein complex that catalyzes intramembrane proteolysis associated with Alzheimer's disease and cancer. Here, we have developed potent sulfonamide clickable photoaffinity probes that target γ-secretase in vitro and in cells by incorporating various photoreactive groups and walking the clickable alkyne handle to different positions around the molecule. We found that benzophenone is preferred over diazirine as a photoreactive group within the sulfonamide scaffold for labeling γ-secretase. Intriguingly, the placement of the alkyne at different positions has little effect on probe potency but has a significant impact on the efficiency of labeling of γ-secretase. Moreover, the optimized clickable photoprobe, 163-BP3, was utilized as a cellular probe to effectively assess the target engagement of inhibitors with γ-secretase in primary neuronal cells. In addition, biotinylated 163-BP3 probes were developed and used to capture the native γ-secretase complex in the 3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonate (CHAPSO) solubilized state. Taken together, these next generation clickable and biotinylated sulfonamide probes offer new tools to study γ-secretase in biochemical and cellular systems. Finally, the data provide insights into structural features of the sulfonamide inhibitor binding site in relation to the active site and into the design of clickable photoaffinity probes.

Entities:  

Keywords:  Alzheimer’s disease; benzophenone; click walking; clickable photoaffinity probe; diazirine; presenilin; β-amyloid

Mesh:

Substances:

Year:  2016        PMID: 27253220      PMCID: PMC5576034          DOI: 10.1021/acschemneuro.6b00127

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  47 in total

1.  Phenylpiperidine-type γ-secretase modulators target the transmembrane domain 1 of presenilin 1.

Authors:  Yu Ohki; Takuya Higo; Kengo Uemura; Naoaki Shimada; Satoko Osawa; Oksana Berezovska; Satoshi Yokoshima; Tohru Fukuyama; Taisuke Tomita; Takeshi Iwatsubo
Journal:  EMBO J       Date:  2011-10-14       Impact factor: 11.598

2.  Design and synthesis of minimalist terminal alkyne-containing diazirine photo-crosslinkers and their incorporation into kinase inhibitors for cell- and tissue-based proteome profiling.

Authors:  Zhengqiu Li; Piliang Hao; Lin Li; Chelsea Y J Tan; Xiamin Cheng; Grace Y J Chen; Siu Kwan Sze; Han-Ming Shen; Shao Q Yao
Journal:  Angew Chem Int Ed Engl       Date:  2013-06-10       Impact factor: 15.336

3.  Comparison of the reactivity of carbohydrate photoaffinity probes with different photoreactive groups.

Authors:  Kaori Sakurai; Shimpei Ozawa; Rika Yamada; Tomoki Yasui; Sakae Mizuno
Journal:  Chembiochem       Date:  2014-05-27       Impact factor: 3.164

4.  Familial Alzheimer disease presenilin-1 mutations alter the active site conformation of γ-secretase.

Authors:  De-Ming Chau; Christina J Crump; Jennifer C Villa; David A Scheinberg; Yue-Ming Li
Journal:  J Biol Chem       Date:  2012-03-29       Impact factor: 5.157

5.  Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1.

Authors:  Y M Li; M Xu; M T Lai; Q Huang; J L Castro; J DiMuzio-Mower; T Harrison; C Lellis; A Nadin; J G Neduvelil; R B Register; M K Sardana; M S Shearman; A L Smith; X P Shi; K C Yin; J A Shafer; S J Gardell
Journal:  Nature       Date:  2000-06-08       Impact factor: 49.962

Review 6.  Benzophenone photophores in biochemistry.

Authors:  G Dormán; G D Prestwich
Journal:  Biochemistry       Date:  1994-05-17       Impact factor: 3.162

7.  Substrate-targeting gamma-secretase modulators.

Authors:  Thomas L Kukar; Thomas B Ladd; Maralyssa A Bann; Patrick C Fraering; Rajeshwar Narlawar; Ghulam M Maharvi; Brent Healy; Robert Chapman; Alfred T Welzel; Robert W Price; Brenda Moore; Vijayaraghavan Rangachari; Bernadette Cusack; Jason Eriksen; Karen Jansen-West; Christophe Verbeeck; Debra Yager; Christopher Eckman; Wenjuan Ye; Sarah Sagi; Barbara A Cottrell; Justin Torpey; Terrone L Rosenberry; Abdul Fauq; Michael S Wolfe; Boris Schmidt; Dominic M Walsh; Edward H Koo; Todd E Golde
Journal:  Nature       Date:  2008-06-12       Impact factor: 49.962

8.  Divergent synthesis of multifunctional molecular probes to elucidate the enzyme specificity of dipeptidic gamma-secretase inhibitors.

Authors:  Haruhiko Fuwa; Yasuko Takahashi; Yu Konno; Naoto Watanabe; Hiroyuki Miyashita; Makoto Sasaki; Hideaki Natsugari; Toshiyuki Kan; Tohru Fukuyama; Taisuke Tomita; Takeshi Iwatsubo
Journal:  ACS Chem Biol       Date:  2007-05-25       Impact factor: 5.100

9.  Affinity-based probes based on type II kinase inhibitors.

Authors:  Pratistha Ranjitkar; B Gayani K Perera; Danielle L Swaney; Daniel L Swaney; Sanjay B Hari; Eric T Larson; Ratika Krishnamurty; Ethan A Merritt; Judit Villén; Dustin J Maly
Journal:  J Am Chem Soc       Date:  2012-11-06       Impact factor: 15.419

Review 10.  Photoaffinity labeling in target- and binding-site identification.

Authors:  Ewan Smith; Ian Collins
Journal:  Future Med Chem       Date:  2015       Impact factor: 3.808

View more
  8 in total

1.  Clickable photoaffinity ligands for the human serotonin transporter based on the selective serotonin reuptake inhibitor (S)-citalopram.

Authors:  Nageswari Yarravarapu; Laura Geffert; Christopher K Surratt; Michael Cascio; David J Lapinsky
Journal:  Bioorg Med Chem Lett       Date:  2018-09-22       Impact factor: 2.823

2.  Mapping the Binding Site of BMS-708163 on γ-Secretase with Cleavable Photoprobes.

Authors:  Natalya Gertsik; Christopher W Am Ende; Kieran F Geoghegan; Chuong Nguyen; Paramita Mukherjee; Scot Mente; Uthpala Seneviratne; Douglas S Johnson; Yue-Ming Li
Journal:  Cell Chem Biol       Date:  2017-01-05       Impact factor: 8.116

3.  Structure-activity relationships of sulfonamides derived from carvacrol and their potential for the treatment of Alzheimer's disease.

Authors:  Márcia Maria de Souza; Marina Corrêa Andreolla; Thaís Cecília Ribeiro; Ana Elisa Gonçalves; Alex Rogério Medeiros; Anacleto Silva de Souza; Leonardo Luiz Gomes Ferreira; Adriano Defini Andricopulo; Rosendo Augusto Yunes; Aldo Sena de Oliveira
Journal:  RSC Med Chem       Date:  2020-02-14

Review 4.  Current advances of carbene-mediated photoaffinity labeling in medicinal chemistry.

Authors:  Sha-Sha Ge; Biao Chen; Yuan-Yuan Wu; Qing-Su Long; Yong-Liang Zhao; Pei-Yi Wang; Song Yang
Journal:  RSC Adv       Date:  2018-08-20       Impact factor: 4.036

Review 5.  γ-Secretase inhibitors and modulators: Mechanistic insights into the function and regulation of γ-Secretase.

Authors:  Pengju Nie; Abhishek Vartak; Yue-Ming Li
Journal:  Semin Cell Dev Biol       Date:  2020-04-02       Impact factor: 7.727

6.  Imaging of Cancer γ-Secretase Activity Using an Inhibitor-Based PET Probe.

Authors:  Pengju Nie; Teja Kalidindi; Veronica L Nagle; Xianzhong Wu; Thomas Li; George P Liao; Georgia Frost; Kelly E Henry; Blesida Punzalan; Lukas M Carter; Jason S Lewis; Naga Vara Kishore Pillarsetty; Yue-Ming Li
Journal:  Clin Cancer Res       Date:  2021-09-02       Impact factor: 12.531

Review 7.  γ-Secretase in Alzheimer's disease.

Authors:  Ji-Yeun Hur
Journal:  Exp Mol Med       Date:  2022-04-08       Impact factor: 12.153

8.  The innate immunity protein IFITM3 modulates γ-secretase in Alzheimer's disease.

Authors:  Ji-Yeun Hur; Georgia R Frost; Xianzhong Wu; Christina Crump; Si Jia Pan; Eitan Wong; Marilia Barros; Thomas Li; Pengju Nie; Yujia Zhai; Jen Chyong Wang; Julia Tcw; Lei Guo; Andrew McKenzie; Chen Ming; Xianxiao Zhou; Minghui Wang; Yotam Sagi; Alan E Renton; Bianca T Esposito; Yong Kim; Katherine R Sadleir; Ivy Trinh; Robert A Rissman; Robert Vassar; Bin Zhang; Douglas S Johnson; Eliezer Masliah; Paul Greengard; Alison Goate; Yue-Ming Li
Journal:  Nature       Date:  2020-09-02       Impact factor: 49.962

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.